1.1 Articolo in rivista: [40134] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 14.281 a 14.300 di 40.134
Titolo Data di pubblicazione Autore(i) File
GOLIMUMAB: CLINICAL UPDATE ON ITS USE FOR ULCERATIVE COLITIS 1-gen-2015 Gilardi, D; Fiorino, G; Allocca, M; Bravata, I; Danese, S
Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis 1-gen-2014 Panaccione, R; Ghosh, S; Middleton, S; Marquez, Jr; Scott, Bb; Flint, L; Van Hoogstraten, Hjf; Chen, Ac; Zheng, Hz; Danese, S; Rutgeerts, P
Mesenteric Vascular Thromboembolism in Inflammatory Bowel Disease: A Single Center Experience 1-gen-2011 Jackson, Cs; Fryer, J; Danese, S; Vanagunas, A; Polensky, S; Buchman, Al
Serum Bile Acids Profiling in Inflammatory Bowel Disease Patients Treated with Anti-TNFs 1-gen-2019 Roda, G; Porru, E; Katsanos, K; Skamnelos, A; Kyriakidi, K; Fiorino, G; Christodoulou, D; Danese, S; Roda, A
IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy 1-gen-2017 Furfaro, F; Gilardi, D; Allocca, M; Cicerone, C; Correale, C; Fiorino, G; Danese, S
Granulocyte colony-stimulating factor: A novel mediator of T cell tolerance 1-gen-2005 Rutella, S; Zavala, F; Danese, S; Kared, H; Leone, G
Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis 1-gen-2016 Bonovas, S; Fiorino, G; Allocca, M; Lytras, T; Nikolopoulos, Gk; Peyrin-Biroulet, L; Danese, S
Is It Crohn's Disease? 1-gen-2020 Parigi, Tommaso Lorenzo; Bonifacio, Cristiana; Danese, Silvio
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies 1-gen-2021 Sandborn, William J; Feagan, Brian G; Danese, Silvio; O'Brien, Christopher D; Ott, Elyssa; Marano, Colleen; Baker, Thomas; Zhou, Yiying; Volger, Sheri; Tikhonov, Ilia; Gasink, Christopher; Sands, Bruce E; Ghosh, Subrata
Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience 1-gen-2019 Pouillon, L; Baumann, C; Rousseau, H; Choukour, M; Andrianjafy, C; Danese, S; Peyrin-Biroulet, L
Anti-IL-6 Treatment for Inflammatory Bowel Diseases: Next Cytokine, Next Target 1-gen-2013 Allocca, M; Jovani, M; Fiorino, G; Schreiber, S; Danese, S
Positioning ustekinumab in moderate-to-severe ulcerative colitis: new kid on the block 1-gen-2020 Fiorino, G; Allocca, M; Correale, C; Roda, G; Furfaro, F; Loy, L; Zilli, A; Peyrin-Biroulet, L; Danese, S
Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1 1-gen-2019 Reinisch, W; Bressler, B; Curtis, R; Parikh, A; Yang, H; Rosario, M; Roseth, A; Danese, S; Feagan, B; Sands, Be; Ginsburg, P; Dassopoulos, T; Lewis, J; Xu, J; Wyant, T
Platelet activation and the CD40/CD40 ligand pathway: Mechanisms and implications for human disease 1-gen-2005 Danese, S; Fiocchi, C
Physicians' perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey 1-gen-2018 Olivera, P; Sandborn, Wj; Panes, J; Baumann, C; D'Haens, G; Vermeire, S; Danese, S; Peyrin-Biroulet, L
Evolving Treatment Algorithms in Crohn's Disease 1-gen-2018 Wisniewski, A; Danese, S; Peyrin-Biroulet, L
Vedolizumab for the treatment of Crohn's disease 1-gen-2018 Argollo, M; Fiorino, G; Peyrin-Biroulet, L; Danese, S
Drug Development for Inflammatory Bowel Disease: Interaction Among Academia, Industry and Regulatory Authorities 1-gen-2016 Danese, S; Vermeire, S
JAK selectivity: more precision less troubles 1-gen-2020 Roda, Giulia; Dal Buono, Arianna; Argollo, Marjorie; Danese, Silvio
Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis 1-gen-2017 Allen, Pb; Olivera, P; Emery, P; Moulin, D; Jouzeau, Jy; Netter, P; Danese, S; Feagan, B; Sandborn, Wj; Peyrin-Biroulet, L
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 14.281 a 14.300 di 40.134
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista40134
Autore
  • MONTORSI, FRANCESCO1703
  • FILIPPI, MASSIMO1688
  • METRA, MARCO1348
  • COMI, GIANCARLO1193
  • BRIGANTI, ALBERTO1190
  • BANDELLO, FRANCESCO1059
  • CICERI, FABIO832
  • ALFIERI, OTTAVIO811
  • FALCONI, MASSIMO786
  • DANESE, SILVIO722
Data di pubblicazione
  • In corso di stampa9
  • 2020 - 202712186
  • 2010 - 201915980
  • 2000 - 20097460
  • 1990 - 19993486
  • 1980 - 1989935
  • 1970 - 197977
  • 1959 - 19591
Editore
  • Elsevier Inc.823
  • Elsevier B.V.809
  • Springer Science and Business Med...552
  • John Wiley and Sons Inc549
  • Oxford University Press506
  • Lippincott Williams and Wilkins435
  • Springer374
  • Elsevier Ltd350
  • MDPI348
  • Springer Nature296
Rivista
  • EUROPEAN UROLOGY535
  • BLOOD372
  • PLOS ONE313
  • JOURNAL OF NEUROLOGY291
  • EUROPEAN JOURNAL OF HEART FAILURE281
  • NEUROLOGY270
  • DIGESTIVE AND LIVER DISEASE245
  • EUROPEAN HEART JOURNAL225
  • MULTIPLE SCLEROSIS219
  • SCIENTIFIC REPORTS215
Keyword
  • Humans3553
  • Male2080
  • Female1864
  • Middle Aged1472
  • Aged1290
  • Adult1100
  • COVID-19636
  • Retrospective Studies628
  • Treatment Outcome603
  • Prognosis483
Lingua
  • eng29490
  • ita1971
  • fre65
  • und55
  • spa34
  • ger26
  • por12
  • enm6
  • rus6
  • grc3
Accesso al fulltext
  • no fulltext32003
  • reserved4297
  • open3722
  • partially open104
  • embargoed7
  • mixed1